This study tests a special PET scan that uses a radioactive tracer to detect HER2 protein on cancer cells. The goal is to see if this scan can better identify which patients with metastatic breast cancer will benefit from a targeted drug called T-DXd. About 70 women with advanced…
Sponsor: Renske Altena • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC